Moreover, STC2 overexpression in HNSCC was strongly correlated with reduced overall survival, consistent with reports that STC2 is a poor prognostic marker for patients with renal cell carcinoma and gastric cancer [27, 28]. Here, STC2 is linked to hereditary clear cell renal cell carcinoma.